{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:24:15Z","timestamp":1783988655556,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T00:00:00Z","timestamp":1313712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2415-11-23","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T06:17:03Z","timestamp":1313734623000},"source":"Crossref","is-referenced-by-count":15,"title":["Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension"],"prefix":"10.1186","volume":"11","author":[{"name":"the Xalacom Study Group in China","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Liang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hua","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Xue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Huai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,19]]},"reference":[{"key":"214_CR1","volume-title":"Highlights","author":"Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat","year":"2005","unstructured":"Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat: World Population Prospects: The 2004 Revision. Highlights. 2005, New York: United Nations, Accessed January 18, 2011, [\n                    http:\/\/www.un.org\/esa\/population\/publications\/WPP2004\/2004Highlights_finalrevised.pdf\n                    \n                  ]"},{"key":"214_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/09286580701331974","volume":"14","author":"Q Zhou","year":"2007","unstructured":"Zhou Q, Friedman DS, Lu H, Duan X, Liang Y, Yang X, Wang F, Wang N: The epidemiology of age-related eye diseases in Mainland China. Ophthalmic Epidemiol. 2007, 14: 399-407. 10.1080\/09286580701331974.","journal-title":"Ophthalmic Epidemiol"},{"key":"214_CR3","first-page":"411","volume":"59","author":"PF Hoyng","year":"2000","unstructured":"Hoyng PF, van Beek LM: Pharmacological therapy for glaucoma: a review. Rugs. 2000, 59: 411-434.","journal-title":"Rugs"},{"key":"214_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2165\/00003495-199141040-00002","volume":"41","author":"LM Hurvitz","year":"1991","unstructured":"Hurvitz LM, Kaufman PL, Robin AL, Weinreb RN, Crawford K, Shaw B: New developments in the drug treatment of glaucoma. Drugs. 1991, 41: 514-532. 10.2165\/00003495-199141040-00002.","journal-title":"Drugs"},{"key":"214_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002512-200522010-00001","volume":"22","author":"RE Marquis","year":"2005","unstructured":"Marquis RE, Whitson JT: Management of glaucoma: focus on pharmacological therapy. Drugs Aging. 2005, 22: 1-21. 10.2165\/00002512-200522010-00001.","journal-title":"Drugs Aging"},{"key":"214_CR6","first-page":"CD003167","volume":"4","author":"C Vass","year":"2007","unstructured":"Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L: Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2007, 4: CD003167-","journal-title":"Cochrane Database Syst Rev"},{"key":"214_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00061198-199804000-00006","volume":"7","author":"G Kobelt-Nguyen","year":"1998","unstructured":"Kobelt-Nguyen G, Gerdtham UG, Alm A: Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma. 1998, 7: 95-104.","journal-title":"J Glaucoma"},{"key":"214_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(93)31484-3","volume":"100","author":"CB Toris","year":"1993","unstructured":"Toris CB, Camras CB, Yablonski ME: Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993, 100: 1297-1304.","journal-title":"Ophthalmology"},{"key":"214_CR9","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J, Scandinavian Latanoprost Study Group: Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology. 1995, 102: 1743-1752.","journal-title":"Ophthalmology"},{"key":"214_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/bjo.79.1.12","volume":"79","author":"A Alm","year":"1995","unstructured":"Alm A, Wideng\u00e5rd I, Kjellgren D, S\u00f6derstr\u00f6m M, Fristr\u00f6m B, Heijl A, Stjerschantz J: Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma subjects treated concomitantly with timolol. Br J Ophthalmol. 1995, 79: 12-16. 10.1136\/bjo.79.1.12.","journal-title":"Br J Ophthalmol"},{"key":"214_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB, United States Latanoprost Study Group: Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. Ophthalmology. 1996, 103: 138-147.","journal-title":"Ophthalmology"},{"key":"214_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J, Latanoprost Study Group: A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology. 1996, 103: 126-137.","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"214_CR13","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S0039-6257(02)00310-7","volume":"47","author":"K Hedman","year":"2002","unstructured":"Hedman K, Larsson LI: The effect of latanoprost compared with timolol in African-American, Asian, Caucasian, and Mexican open-angle glaucoma or ocular hypertensive patients. Surv Ophthalmol. 2002, 47 (Suppl 1): S77-89.","journal-title":"Surv Ophthalmol"},{"key":"214_CR14","volume-title":"San Francisco: American Academy of Ophthalmology","author":"American Academy of Ophthalmology","year":"2005","unstructured":"American Academy of Ophthalmology: Primary Open-Angle Glaucoma, Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology. 2005, Accessed: January 18, 2011, [\n                    http:\/\/www.aao.org\/ppp\n                    \n                  ]"},{"key":"214_CR15","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma: 2008, Savona, Italy: DOGMA, Accessed August 10, 2011, [\n                    http:\/\/www.eugs.org\/eng\/EGS_guidelines.asp\n                    \n                  ]3"},{"key":"214_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00061198-199902000-00007","volume":"8","author":"MG Bucci","year":"1999","unstructured":"Bucci MG, the Italian Latanoprost Study Group: Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. J Glaucoma. 1999, 8: 24-30.","journal-title":"J Glaucoma"},{"key":"214_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0161-6420(91)32173-0","volume":"98","author":"PY Lee","year":"1991","unstructured":"Lee PY, Shao H, Camras CB, Podos SM: Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients. Ophthalmology. 1991, 98: 1079-1082.","journal-title":"Ophthalmology"},{"key":"214_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/bjo.78.12.899","volume":"78","author":"AH Rulo","year":"1994","unstructured":"Rulo AH, Greve EL, Hoyng PF: Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol. 1994, 78: 899-902. 10.1136\/bjo.78.12.899.","journal-title":"Br J Ophthalmol"},{"key":"214_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ophtha.2005.06.027","volume":"113","author":"M Diestelhorst","year":"2006","unstructured":"Diestelhorst M, Larsson LI, European-Canadian Latanoprost Fixed Combination Study Group: A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components. Ophthalmology. 2006, 113: 70-76. 10.1016\/j.ophtha.2005.06.027.","journal-title":"Ophthalmology"},{"key":"214_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","volume":"83","author":"JH Gurwitz","year":"1993","unstructured":"Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J: Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993, 83: 711-716. 10.2105\/AJPH.83.5.711.","journal-title":"Am J Public Health"},{"key":"214_CR21","first-page":"233","volume":"26","author":"SC Patel","year":"1995","unstructured":"Patel SC, Spaeth GL: Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995, 26: 233-236.","journal-title":"Ophthalmic Surg"},{"key":"214_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","volume":"144","author":"AL Robin","year":"2007","unstructured":"Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS: Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007, 144: 533-540. 10.1016\/j.ajo.2007.06.012.","journal-title":"Am J Ophthalmol"},{"key":"214_CR23","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1185\/03007990903260129","volume":"25","author":"EJ Higginbotham","year":"2009","unstructured":"Higginbotham EJ, Hansen J, Davis EJ, Walt JG, Guckian A: Glaucoma medication persistence with a fixed combination versus multiple bottles. Curr Med Res Opin. 2009, 25: 2543-2547. 10.1185\/03007990903260129.","journal-title":"Curr Med Res Opin"},{"key":"214_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1600-0420.2007.00882.x","volume":"85","author":"A Chawla","year":"2007","unstructured":"Chawla A, McGalliard JN, Batterbury M: Use of eyedrops in glaucoma: How can we help to reduce non-compliance?. Acta Ophthalmol Scand. 2007, 85: 464-10.1111\/j.1600-0420.2007.00882.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"214_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0002-9394(14)71282-6","volume":"116","author":"WC Stewart","year":"1993","unstructured":"Stewart WC, Chorak RP, Hunt HH, Sethuraman G: Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 1993, 116: 176-181.","journal-title":"Am J Ophthalmol"},{"key":"214_CR26","volume-title":"Eur J Ophthalmol","author":"GCM Rossi","year":"2010","unstructured":"Rossi GCM, Pasinetti GM, Scudeller , Radaelli R, Bianchi PE: Do adherence rates and glaucomatous visual field progression correlate?. Eur J Ophthalmol. 2010."},{"key":"214_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archophthalmol.2009.384","volume":"128","author":"EJ Higginbotham","year":"2010","unstructured":"Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS, United States Fixed-Combination Study Group: Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study. Arch Ophthalmol. 2010, 128: 165-172. 10.1001\/archophthalmol.2009.384.","journal-title":"Arch Ophthalmol"},{"key":"214_CR28","first-page":"1275","volume":"92","author":"C Baudouin","year":"2008","unstructured":"Baudouin C: Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008, 92: 1275-1282.","journal-title":"Acta Ophthalmol"},{"key":"214_CR29","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ophtha.2010.03.024","volume":"117","author":"CA Webers","year":"2010","unstructured":"Webers CA, Beckers HJ, Zeegers MP, Nuijts RM, Hendrikse F, Schouten JS: The intraocular pressure-lowering effect of prostaglandin analogs combined with topical beta-blocker therapy: a systematic review and meta-analysis. Ophthalmology. 2010, 117: 2067-2074. 10.1016\/j.ophtha.2010.03.024.","journal-title":"Ophthalmology"},{"key":"214_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9394(99)00073-2","volume":"128","author":"AG Konstas","year":"1999","unstructured":"Konstas AG, Maltezos AC, Gandi S, Hudgins AC, Stewart WC: Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma. Am J Ophthalmol. 1999, 128: 15-20. 10.1016\/S0002-9394(99)00073-2.","journal-title":"Am J Ophthalmol"},{"key":"214_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0002-9394(02)01460-5","volume":"133","author":"AG Konstas","year":"2002","unstructured":"Konstas AG, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC: A comparison of once-daily morning vs evening dosing of concomitant latanoprost\/timolol. Am J Ophthalmol. 2002, 133: 753-757. 10.1016\/S0002-9394(02)01460-5.","journal-title":"Am J Ophthalmol"},{"key":"214_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archopht.123.7.898","volume":"123","author":"AG Konstas","year":"2005","unstructured":"Konstas AG, Boboridis K, Tzetzi D, Kallinderis K, Jenkins JN, Stewart WC: Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy. Arch Ophthalmol. 2005, 123: 898-902. 10.1001\/archopht.123.7.898.","journal-title":"Arch Ophthalmol"},{"key":"214_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00417-002-0553-0","volume":"240","author":"N Pfeiffer","year":"2002","unstructured":"Pfeiffer N, European Latanoprost Fixed Combination Study Group: A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol. 2002, 240: 893-899. 10.1007\/s00417-002-0553-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"214_CR34","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/archopht.124.11.1553","volume":"124","author":"AG Konstas","year":"2006","unstructured":"Konstas AG, Lake S, Economou AI, Kaltsos K, Jenkins JN, Stewart WC: 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone. Arch Ophthalmol. 2006, 124: 1553-1557. 10.1001\/archopht.124.11.1553.","journal-title":"Arch Ophthalmol"},{"key":"214_CR35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/112067210801800110","volume":"18","author":"T Takmaz","year":"2008","unstructured":"Takmaz T, A\u015fik S, K\u00fcrk\u00e7\u00fco\u011f.ggglu P, Gurdal C, Can I: Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost\/timolol maleate combination. Eur J Ophthalmol. 2008, 18: 60-65.","journal-title":"Eur J Ophthalmol"},{"key":"214_CR36","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0161-6420(93)31496-X","volume":"100","author":"SL Letchinger","year":"1993","unstructured":"Letchinger SL, Frohlichstein D, Glieser DK, Higginbotham EJ, Wilensky JT, Viana MA, Zeimer R: Can the concentration of timolol or the frequency of its administration be reduced?. Ophthalmology. 1993, 100: 1259-1262.","journal-title":"Ophthalmology"},{"key":"214_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajo.2008.05.026","volume":"146","author":"T Kida","year":"2008","unstructured":"Kida T, Liu JH, Weinreb RN: Effects of aging on corneal biomechanical properties and their impact on 24-hour measurement of intraocular pressure. Am J Ophthalmol. 2008, 146: 567-572. 10.1016\/j.ajo.2008.05.026.","journal-title":"Am J Ophthalmol"},{"key":"214_CR38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1167\/iovs.02-0666","volume":"44","author":"JH Liu","year":"2003","unstructured":"Liu JH, Zhang X, Kripke DF, Weinreb RN: Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003, 44: 1586-1590. 10.1167\/iovs.02-0666.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"214_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bjo.2003.018234","volume":"88","author":"M Diestelhorst","year":"2004","unstructured":"Diestelhorst M, Larsson LI, European Latanoprost Fixed Combination Study Group: A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. Br J Ophthalmol. 2004, 88: 199-203. 10.1136\/bjo.2003.018234.","journal-title":"Br J Ophthalmol"},{"key":"214_CR40","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archopht.120.7.915","volume":"120","author":"EJ Higginbotham","year":"2002","unstructured":"Higginbotham EJ, Feldman R, Stiles M, Dubiner H, Fixed Combination Investigative Group: Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. Arch Ophthalmol. 2002, 120: 915-922.","journal-title":"Arch Ophthalmol"},{"key":"214_CR41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/112067211002000411","volume":"20","author":"P Palmberg","year":"2010","unstructured":"Palmberg P, Kim EE, Kwok KK, Tressler CS, Latanoprost\/Timolol Study: A 12-week, randomized, double-masked study of fixed combination latanoprost\/timolol versus latanoprost or timolol monotherapy. Eur J Ophthalmol. 2010, 20: 708-718.","journal-title":"Eur J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-11-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-11-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-11-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-11-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T02:58:26Z","timestamp":1548212306000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-11-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-11-23","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,19]]},"article-number":"23"}}